All In MedTech

FDA Clearance Tracker · P950019-S009

RAY TFC DEVICE AND RAY TFC UNITE DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 2, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 2, 2000

Approved

Time to decision

304 days

Received May 3, 1999. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class II

The decision

FDA number
P950019-S009
Device name
RAY TFC DEVICE AND RAY TFC UNITE DEVICE
Applicant
Stryker Spine
Applicant location
Allendale, NJ
Received
May 3, 1999
Decided
Mar 2, 2000
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P950019

Device type

Device class
Class II
Regulation
21 CFR 888.3080

Every decision under product code MAX

FDA's approval statement

As written in FDA's record.

Modified indications for use for the Ray TFC and Unite Threaded Fusion Cage with instrumentation. These devices are indicated for use with autogenous bone grafts in patients with degenerative disc disease (DDD) at one or two levels for L2 to S1.

Source documents

Other decisions for Stryker Spine

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.